CDH12 and breast cancer: Our data demonstrate that after exposure to chemotherapeutic drugs, breast cancer cells that survive from executioner caspase activation acquire enhanced proliferation and migration through de-repression of CDH12 transcription and the subsequent activation of ERK/CREB signaling (Fig. 6E).